Dutch study scrutinizes outcomes for emergency bleeding treatment
NCT ID NCT05898412
Summary
This study looked back at the medical records of 217 patients in the Netherlands who were hospitalized for severe bleeding while taking certain blood thinners. All patients received a specific drug (andexanet alfa) designed to reverse the blood thinner's effect. The goal was to understand which patients received this treatment, how it was used, and what their health outcomes were, including the risk of blood clots after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Amsterdam, Netherlands
Conditions
Explore the condition pages connected to this study.